RecallGuide.ca
    Health productsUpdated Jan 3, 2026HizentraOfficial source

    Hizentra recall in Canada: Atypical appearance

    Share:

    In plain language

    This recall involves Hizentra, an immune globulin product, sold in Canada. It's being recalled because some syringes have an atypical, viscous, or gelatinous solution. Stop using the product and follow the return steps in the official notice.

    What to do

    • Stop using the product immediately.
    • Check the lot number P100047093.
    • Contact CSL Behring Canada Inc. for instructions.

    Get alerts for recalls like this

    Get email alerts when new recalls affect products in this category.

    Categories (optional)

    No spam. Unsubscribe anytime. We only email when there's a relevant recall.

    Affected products

    • Hizentra, immune globulin (human) 10 ml single used prefilled syringes

      Lot: P100047093

    Why this matters

    Atypical appearance (viscous or gelatinous solution)

    Do I have this product?

    This recall only applies to specific products. Follow the steps below to check.

    1. 1

      Check the product name

      Make sure your product name matches one of the affected products listed above.

    2. 2

      Check the lot number

      Lot numbers identify specific production batches.

      Affected lots: P100047093

    If your product matches one or more of the details above, it may be affected by this recall.

    If your product does not match these details, it is not affected by this recall.

    When in doubt, always check the official notice.

    Want alerts if similar products are recalled in Canada?

    Frequently Asked Questions

    Why was this product recalled?

    Atypical appearance (viscous or gelatinous solution)

    What should consumers do?

    Stop using the product immediately. Check the lot number P100047093. Contact CSL Behring Canada Inc. for instructions.

    Where was the product sold?

    This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.

    Is there a health risk?

    Yes, there may be a health risk. Atypical appearance (viscous or gelatinous solution)

    When was this product recalled?

    This product was recalled on January 16, 2020.

    Is the Hizentra brand affected by this recall?

    Yes, Hizentra products are affected by this recall. This recall involves Hizentra, an immune globulin product, sold in Canada. It's being recalled because some syringes have an atypical, viscous, or gelatinous solution. Stop using the product and follow the return steps in the official notice.